Grouping of Poorly Soluble Low (Cyto)Toxic Particles: Example with 15 Selected Nanoparticles and A549 Human Lung Cells
Poorly soluble, low (cyto)toxic particles (PSLTs) are often regarded as one group, but it is important that these particles can be further differentiated based on their bioactivity. Currently, there are no biological endpoint based groupings for inhaled nanoparticles (NPs) that would allow us to sub...
Main Authors: | Veno Kononenko, David B. Warheit, Damjana Drobne |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/9/5/704 |
Similar Items
-
In Vitro Cytotoxicity Evaluation of the Magnéli Phase Titanium Suboxides (TixO2x−1) on A549 Human Lung Cells
by: Veno Kononenko, et al.
Published: (2019-01-01) -
Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability
by: Prakash Khadka, et al.
Published: (2014-12-01) -
Even lobar deposition of poorly soluble gold nanoparticles (AuNPs) is similar to that of soluble silver nanoparticles (AgNPs)
by: Hoi Pin Kim, et al.
Published: (2020-10-01) -
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
by: Varaporn Buraphacheep Junyaprasert, et al.
Published: (2015-02-01) -
An overview of techniques for multifold enhancement in solubility of poorly soluble drugs
by: Ansari Mohammad Javed
Published: (2019-12-01)